Hypoxia reduces hormone responsiveness of human breast cancer cells

Japanese Journal of Cancer Research

Volumn 92, Issue 10, 2001, Pages 1093-1101

  Kurebayashi, Junichi ^a   Otsuki, Takemi ^b   Moriya, Takuya ^c   Sonoo, Hiroshi ^a  

^a Kawasaki Medical School   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Breast cancer; Estrogen receptor; Hormone resistance; Hypoxia; Hypoxia inducible factor 1

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GESTAGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TUMOR PROMOTION;

ANOXIA; BREAST NEOPLASMS; CELL DIVISION; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; OXYGEN; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034759792     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01064.x     Document Type: Article

References (27)

1. McGuire Memorial Lecture. Antiestrogens: Mechanisms of action and resistance in breast cancer
2. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice
3. Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis
4. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro
5. Paradoxical hormone responses of KPL-1 breast cancer cells in vivo: A significant role of angiogenesis in tumor growth
6. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
7. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
8. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages
9. Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression
10. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth
11. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
12. The hypoxic cell: A target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture
13. Levels of hypoxia-inducible factor-1alpha during breast carcinogenesis
14. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ
15. A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice
16. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors
17. Estrogen receptors in human myeloma cells
18. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
19. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression
20. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
21. Oestrogen receptor expression in ductal carcinoma in situ of the breast: Relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein
22. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer
23. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy
24. Inhibition of angiogenesis by antiestrogens
25. Tamoxifen induces hypoxia in MCF-7 xenografts
26. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: Possible involvement of antiangiogenic action of growth inhibition
27. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies